Atea Pharmaceuticals Inc. Common Stock is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Their innovative approach and skilled team have positioned them as leaders in the field of antiviral drug development.
- Latest
- Trending
